| Filed On | Filing |
|---|---|
| 05 Nov 2026 | SCHEDULE 13G/A |
| 03 Nov 2026 | 10-Q |
| 27 Oct 2026 |
8-K: Results of Operations and Financial Condition
Redwood City, CA - October 27, 2026 – Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the third quarter of 2026 ende... |
| 03 Sep 2026 |
Form 4: French Glendon E. Iii, Director
Sold 41,882 shares ($94.7K) |
| 03 Sep 2026 |
Form 4: Radhakrishnan Srikanth, Chief Science & Techn. Officer
Sold 14,245 shares ($32.2K) |
| 03 Sep 2026 |
Form 4: Lehman David Aaron, General Counsel
Sold 14,334 shares ($32.4K) |
| 03 Sep 2026 |
Form 4: Rose Geoffrey Beran, Chief Commercial Officer
Sold 7,879 shares ($17.8K) |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 04 Aug 2026 | 10-Q |
| 29 Jul 2026 |
8-K: Results of Operations and Financial Condition
Redwood City, CA - July 29, 2026 – Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the second quarter of 2026 ended ... |
| 29 Jul 2026 | SCHEDULE 13G/A |
| 09 Jun 2026 |
Form 4: Burns Thomas William, Director
Received 40,000 shares as a grant or award |
| 09 Jun 2026 |
Form 4: Ferrari Richard, Director
Received 40,000 shares as a grant or award |
| 09 Jun 2026 |
Form 4: Florin Daniel P, Director
Received 40,000 shares as a grant or award |
| 09 Jun 2026 |
Form 4: Melenikiotou Georgia, Director
Received 40,000 shares as a grant or award |
| 09 Jun 2026 |
Form 4: Sullivan Tiffany, Director
Received 40,000 shares as a grant or award |
| 09 Jun 2026 |
Form 4: Mead Dana G Jr., Director
Received 40,000 shares as a grant or award |
| 04 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 4, 2026, Pulmonx Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). A total of 32,645,270 shares of the Company’s common stock were present or represented by proxy at the Annual Meeti... |
| 03 Jun 2026 |
Form 4: Radhakrishnan Srikanth, Chief Science &Techn. Officer
Sold 14,497 shares ($22.3K) |
| 03 Jun 2026 |
Form 4: Lehman David Aaron, GENERAL COUNSEL
Sold 14,594 shares ($22.5K) |
Loading...